Treatment of esophageal cancer: surgical outcomes of 335 cases operated in a single center

Detalhes bibliográficos
Autor(a) principal: FERREIRA,RAPHAELLA PAULA
Data de Publicação: 2021
Outros Autores: BUSSYGUIN,DANILO SAAVEDRA, TROMBETTA,HYGOR, MELO,VICTOR JOSE DORNELAS, XIMENEZ,DANIELE REZENDE, PRETI,VINICIUS BASSO, VALLADARES,GERARDO CRISTINO GAVARRETE, TOMASICH,FLAVIO DANIEL SAAVEDRA, ABREU,PHILLIPE
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista do Colégio Brasileiro de Cirurgiões
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912021000100206
Resumo: ABSTRACT Objectives: the surgical approach persists as the main treatment for esophageal cancer. This study compares the patients of the same institution over time at three different times. Methods: this is a retrospective, observational, descriptive study comparing the surgical outcomes obtained by the Division of Surgical Oncology of Erasto Gaertner Hospital. The sample was divided into Period 1 (1987-1997), Period 2 (1998-2003) and Period 3 (2007-2015). Survival rates and disease-free survival were estimated by the Kaplan-Maier method. Survival predictors were identified with Cox regression. ANOVA test was used for comparison between groups. Data were analyzed with SPSS 25.0 and STATA 16, and p<0.05 was considered statistically significant. Results: a total of 335 patients underwent esophagectomy or esophagogastrectomy. When the clinical characteristics of the 3 groups were compared, there was no statistically significant difference. Neoadjuvance was significantly higher in Period 3 (55.4% of patients). We found a histological change in the diagnosis over time, with a significant increase in adenocarcinoma. Morbidity and mortality rates were higher in Period 3. The main complications were pulmonary and anastomotic fistulas. Overall survival in 5 years increased over time, reaching 59.7% in Period 3. Conclusions: better neoadjuvant treatment contributed to increase the global survival of patients, despite greater rate of immediate complications to surgery.
id CBC-1_c4a5a8a8d5cd9adf6f3fdfe8a64f3e59
oai_identifier_str oai:scielo:S0100-69912021000100206
network_acronym_str CBC-1
network_name_str Revista do Colégio Brasileiro de Cirurgiões
repository_id_str
spelling Treatment of esophageal cancer: surgical outcomes of 335 cases operated in a single centerEsophageal NeoplasmsEsophagectomyPostoperative ComplicationsTreatment OutcomeABSTRACT Objectives: the surgical approach persists as the main treatment for esophageal cancer. This study compares the patients of the same institution over time at three different times. Methods: this is a retrospective, observational, descriptive study comparing the surgical outcomes obtained by the Division of Surgical Oncology of Erasto Gaertner Hospital. The sample was divided into Period 1 (1987-1997), Period 2 (1998-2003) and Period 3 (2007-2015). Survival rates and disease-free survival were estimated by the Kaplan-Maier method. Survival predictors were identified with Cox regression. ANOVA test was used for comparison between groups. Data were analyzed with SPSS 25.0 and STATA 16, and p<0.05 was considered statistically significant. Results: a total of 335 patients underwent esophagectomy or esophagogastrectomy. When the clinical characteristics of the 3 groups were compared, there was no statistically significant difference. Neoadjuvance was significantly higher in Period 3 (55.4% of patients). We found a histological change in the diagnosis over time, with a significant increase in adenocarcinoma. Morbidity and mortality rates were higher in Period 3. The main complications were pulmonary and anastomotic fistulas. Overall survival in 5 years increased over time, reaching 59.7% in Period 3. Conclusions: better neoadjuvant treatment contributed to increase the global survival of patients, despite greater rate of immediate complications to surgery.Colégio Brasileiro de Cirurgiões2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912021000100206Revista do Colégio Brasileiro de Cirurgiões v.48 2021reponame:Revista do Colégio Brasileiro de Cirurgiõesinstname:Colégio Brasileiro de Cirurgiões (CBC)instacron:CBC10.1590/0100-6991e-20202723info:eu-repo/semantics/openAccessFERREIRA,RAPHAELLA PAULABUSSYGUIN,DANILO SAAVEDRATROMBETTA,HYGORMELO,VICTOR JOSE DORNELASXIMENEZ,DANIELE REZENDEPRETI,VINICIUS BASSOVALLADARES,GERARDO CRISTINO GAVARRETETOMASICH,FLAVIO DANIEL SAAVEDRAABREU,PHILLIPEeng2021-02-11T00:00:00Zoai:scielo:S0100-69912021000100206Revistahttp://www.scielo.br/rcbcONGhttps://old.scielo.br/oai/scielo-oai.php||revistacbc@cbc.org.br1809-45460100-6991opendoar:2021-02-11T00:00Revista do Colégio Brasileiro de Cirurgiões - Colégio Brasileiro de Cirurgiões (CBC)false
dc.title.none.fl_str_mv Treatment of esophageal cancer: surgical outcomes of 335 cases operated in a single center
title Treatment of esophageal cancer: surgical outcomes of 335 cases operated in a single center
spellingShingle Treatment of esophageal cancer: surgical outcomes of 335 cases operated in a single center
FERREIRA,RAPHAELLA PAULA
Esophageal Neoplasms
Esophagectomy
Postoperative Complications
Treatment Outcome
title_short Treatment of esophageal cancer: surgical outcomes of 335 cases operated in a single center
title_full Treatment of esophageal cancer: surgical outcomes of 335 cases operated in a single center
title_fullStr Treatment of esophageal cancer: surgical outcomes of 335 cases operated in a single center
title_full_unstemmed Treatment of esophageal cancer: surgical outcomes of 335 cases operated in a single center
title_sort Treatment of esophageal cancer: surgical outcomes of 335 cases operated in a single center
author FERREIRA,RAPHAELLA PAULA
author_facet FERREIRA,RAPHAELLA PAULA
BUSSYGUIN,DANILO SAAVEDRA
TROMBETTA,HYGOR
MELO,VICTOR JOSE DORNELAS
XIMENEZ,DANIELE REZENDE
PRETI,VINICIUS BASSO
VALLADARES,GERARDO CRISTINO GAVARRETE
TOMASICH,FLAVIO DANIEL SAAVEDRA
ABREU,PHILLIPE
author_role author
author2 BUSSYGUIN,DANILO SAAVEDRA
TROMBETTA,HYGOR
MELO,VICTOR JOSE DORNELAS
XIMENEZ,DANIELE REZENDE
PRETI,VINICIUS BASSO
VALLADARES,GERARDO CRISTINO GAVARRETE
TOMASICH,FLAVIO DANIEL SAAVEDRA
ABREU,PHILLIPE
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv FERREIRA,RAPHAELLA PAULA
BUSSYGUIN,DANILO SAAVEDRA
TROMBETTA,HYGOR
MELO,VICTOR JOSE DORNELAS
XIMENEZ,DANIELE REZENDE
PRETI,VINICIUS BASSO
VALLADARES,GERARDO CRISTINO GAVARRETE
TOMASICH,FLAVIO DANIEL SAAVEDRA
ABREU,PHILLIPE
dc.subject.por.fl_str_mv Esophageal Neoplasms
Esophagectomy
Postoperative Complications
Treatment Outcome
topic Esophageal Neoplasms
Esophagectomy
Postoperative Complications
Treatment Outcome
description ABSTRACT Objectives: the surgical approach persists as the main treatment for esophageal cancer. This study compares the patients of the same institution over time at three different times. Methods: this is a retrospective, observational, descriptive study comparing the surgical outcomes obtained by the Division of Surgical Oncology of Erasto Gaertner Hospital. The sample was divided into Period 1 (1987-1997), Period 2 (1998-2003) and Period 3 (2007-2015). Survival rates and disease-free survival were estimated by the Kaplan-Maier method. Survival predictors were identified with Cox regression. ANOVA test was used for comparison between groups. Data were analyzed with SPSS 25.0 and STATA 16, and p<0.05 was considered statistically significant. Results: a total of 335 patients underwent esophagectomy or esophagogastrectomy. When the clinical characteristics of the 3 groups were compared, there was no statistically significant difference. Neoadjuvance was significantly higher in Period 3 (55.4% of patients). We found a histological change in the diagnosis over time, with a significant increase in adenocarcinoma. Morbidity and mortality rates were higher in Period 3. The main complications were pulmonary and anastomotic fistulas. Overall survival in 5 years increased over time, reaching 59.7% in Period 3. Conclusions: better neoadjuvant treatment contributed to increase the global survival of patients, despite greater rate of immediate complications to surgery.
publishDate 2021
dc.date.none.fl_str_mv 2021-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912021000100206
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912021000100206
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/0100-6991e-20202723
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Colégio Brasileiro de Cirurgiões
publisher.none.fl_str_mv Colégio Brasileiro de Cirurgiões
dc.source.none.fl_str_mv Revista do Colégio Brasileiro de Cirurgiões v.48 2021
reponame:Revista do Colégio Brasileiro de Cirurgiões
instname:Colégio Brasileiro de Cirurgiões (CBC)
instacron:CBC
instname_str Colégio Brasileiro de Cirurgiões (CBC)
instacron_str CBC
institution CBC
reponame_str Revista do Colégio Brasileiro de Cirurgiões
collection Revista do Colégio Brasileiro de Cirurgiões
repository.name.fl_str_mv Revista do Colégio Brasileiro de Cirurgiões - Colégio Brasileiro de Cirurgiões (CBC)
repository.mail.fl_str_mv ||revistacbc@cbc.org.br
_version_ 1754209215061164032